PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Murray sold 35,975 shares of PACS Group stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $43.09, for a total transaction of $1,550,162.75. Following the sale, the chief executive officer owned 54,435,966 shares of the company’s stock, valued at approximately $2,345,645,774.94. This trade represents a 0.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jason Hulse Murray also recently made the following trade(s):
- On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The shares were sold at an average price of $42.48, for a total transaction of $30,458.16.
- On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The shares were sold at an average price of $42.66, for a total transaction of $1,033,395.84.
- On Friday, October 2nd, Jason Murray sold 26,052 shares of PACS Group stock. The stock was sold at an average price of $42.51, for a total transaction of $1,107,470.52.
- On Thursday, October 1st, Jason Murray sold 33,032 shares of PACS Group stock. The stock was sold at an average price of $41.13, for a total transaction of $1,358,606.16.
- On Monday, September 14th, Jason Murray sold 317 shares of PACS Group stock. The shares were sold at an average price of $45.03, for a total value of $14,274.51.
- On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The stock was sold at an average price of $45.23, for a total value of $476,226.67.
- On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The stock was sold at an average price of $45.16, for a total value of $396,098.36.
- On Wednesday, September 9th, Jason Murray sold 4,758 shares of PACS Group stock. The stock was sold at an average price of $43.33, for a total value of $206,164.14.
- On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The shares were sold at an average price of $43.49, for a total value of $1,046,238.93.
- On Friday, September 4th, Jason Murray sold 23,072 shares of PACS Group stock. The shares were sold at an average price of $42.69, for a total value of $984,943.68.
PACS Group Trading Up 0.5%
NYSE PACS traded up $0.21 during trading hours on Wednesday, hitting $43.02. 673,130 shares of the company’s stock were exchanged, compared to its average volume of 899,083. The business’s 50 day moving average is $43.81 and its 200-day moving average is $39.81. PACS Group, Inc. has a 12-month low of $10.31 and a 12-month high of $49.49. The firm has a market capitalization of $6.81 billion, a P/E ratio of 25.01, a price-to-earnings-growth ratio of 1.33 and a beta of -0.08. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of PACS. Squarepoint Ops LLC grew its stake in PACS Group by 94.7% during the second quarter. Squarepoint Ops LLC now owns 59,523 shares of the company’s stock worth $2,538,000 after buying an additional 28,945 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in shares of PACS Group during the 2nd quarter valued at $1,893,000. Engineers Gate Manager LP acquired a new position in shares of PACS Group during the 2nd quarter valued at $1,132,000. Smith Group Asset Management LLC purchased a new stake in PACS Group during the 1st quarter worth $771,000. Finally, Principal Financial Group Inc. acquired a new stake in PACS Group in the 1st quarter valued at $3,171,000.
Wall Street Analyst Weigh In
Several equities analysts recently commented on the stock. Zacks Research lowered shares of PACS Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 9th. UBS Group lifted their price target on shares of PACS Group from $57.00 to $60.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Royal Bank Of Canada boosted their price objective on shares of PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research note on Thursday, August 6th. Truist Financial set a $62.00 price objective on PACS Group in a report on Wednesday, September 2nd. Finally, JPMorgan Chase & Co. increased their target price on PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a research report on Friday, September 4th. Five investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, PACS Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $58.80.
Read Our Latest Report on PACS Group
About PACS Group
PACS Group, Inc is a healthcare services company that operates skilled nursing and other post-acute care facilities in the United States. Its facilities provide services for patients who require medical care, rehabilitation, recovery support, or assistance with daily activities following hospitalization or other acute health events.
The company’s services generally include skilled nursing, physical and occupational therapy, speech therapy, long-term care, short-term rehabilitation, and other specialized post-acute programs.
Further Reading
- Five stocks we like better than PACS Group
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
